FERRANTINI, CECILIA
 Distribuzione geografica
Continente #
NA - Nord America 8.481
EU - Europa 7.002
AS - Asia 3.900
SA - Sud America 413
Continente sconosciuto - Info sul continente non disponibili 188
AF - Africa 86
OC - Oceania 54
Totale 20.124
Nazione #
US - Stati Uniti d'America 8.314
PL - Polonia 2.252
RU - Federazione Russa 1.721
IT - Italia 1.395
SG - Singapore 1.130
CN - Cina 984
HK - Hong Kong 559
VN - Vietnam 403
IE - Irlanda 370
BR - Brasile 311
KR - Corea 286
SE - Svezia 284
DE - Germania 206
FR - Francia 184
FI - Finlandia 167
GB - Regno Unito 125
JO - Giordania 109
CA - Canada 103
IN - India 103
CH - Svizzera 90
BD - Bangladesh 72
ID - Indonesia 68
JP - Giappone 67
AU - Australia 51
BE - Belgio 41
AR - Argentina 37
NL - Olanda 35
ES - Italia 31
ZA - Sudafrica 27
MX - Messico 24
UA - Ucraina 23
IQ - Iraq 20
TR - Turchia 20
CI - Costa d'Avorio 18
GR - Grecia 15
EC - Ecuador 12
VE - Venezuela 12
PK - Pakistan 11
AT - Austria 10
LT - Lituania 10
NG - Nigeria 10
SA - Arabia Saudita 10
CL - Cile 8
CO - Colombia 8
JM - Giamaica 8
MA - Marocco 8
PY - Paraguay 8
RO - Romania 8
PH - Filippine 7
CR - Costa Rica 6
EG - Egitto 6
KZ - Kazakistan 6
LU - Lussemburgo 6
UZ - Uzbekistan 6
AL - Albania 5
BO - Bolivia 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
GT - Guatemala 5
PE - Perù 5
PR - Porto Rico 5
TW - Taiwan 5
AZ - Azerbaigian 4
BJ - Benin 4
HN - Honduras 4
KE - Kenya 4
MY - Malesia 4
NO - Norvegia 4
UY - Uruguay 4
IL - Israele 3
IR - Iran 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
GE - Georgia 2
HU - Ungheria 2
KG - Kirghizistan 2
MN - Mongolia 2
NP - Nepal 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AI - Anguilla 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
KW - Kuwait 1
LB - Libano 1
LC - Santa Lucia 1
Totale 19.928
Città #
Warsaw 2.247
Santa Clara 1.623
Ashburn 1.134
Singapore 802
Fairfield 666
Hong Kong 480
Dublin 363
Chandler 362
Woodbridge 321
San Jose 302
Florence 299
Seattle 294
Seoul 275
Cambridge 249
Houston 245
Beijing 234
Milan 218
Ann Arbor 202
Wilmington 196
Hefei 175
Council Bluffs 166
Los Angeles 136
Buffalo 120
Altamura 113
Munich 113
Lawrence 111
Ho Chi Minh City 107
Rome 95
Lauterbourg 93
New York 92
The Dalles 91
Princeton 88
Bern 87
Helsinki 75
Moscow 72
Dallas 71
Hanoi 68
Boston 64
Dong Ket 62
Jakarta 62
Shanghai 59
Tokyo 58
San Diego 56
Mumbai 43
Boardman 40
Brussels 40
Kent 40
Medford 39
Melbourne 39
São Paulo 37
Bologna 36
Turku 35
Clifton 32
Frankfurt am Main 29
Naples 28
Paris 28
Chicago 26
Phoenix 26
London 25
Montreal 25
Orem 25
Guangzhou 22
Lappeenranta 22
Norwalk 21
Redondo Beach 21
Turin 20
Redwood City 19
Toronto 19
Abidjan 18
Poggio A Caiano 17
Barcelona 16
Chennai 16
Da Nang 16
Rio de Janeiro 16
Johannesburg 15
Palermo 15
Amsterdam 14
Atlanta 14
Falkenstein 14
Falls Church 14
Poplar 14
Dearborn 13
Denver 13
Siena 13
Andover 12
Haiphong 12
Ankara 11
Brooklyn 11
Tianjin 11
Figino 10
Perugia 10
Yubileyny 10
Abuja 9
New Delhi 9
Pisa 9
Redmond 9
Baghdad 8
Bari 8
Bengaluru 8
Brasília 8
Totale 13.876
Nome #
Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy. 440
Atrial Remodeling in Hypertrophic Cardiomyopathy 410
Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation. 379
Pathogenesis of hypertrophic cardiomyopathy is mutation rather than disease specific: A comparison of the cardiac troponin T E163R and R92Q mouse models 353
Regulation of intracellular Na+ in health and disease: pathophysiological mechanisms and implications for treatment 327
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 317
Myocardial Dysfunction in Hypertrophic Cardiomyopathy: Primary Effects of Sarcomeric Mutations Versus Secondary EC-Coupling Remodelling 305
Mechanical and Energetic Consequences of HCM-Causing Mutations 302
Late sodium current inhibitors to treat exercise induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium. 300
β Blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy 294
Electrical defects of the transverse-axial tubular system in cardiac diseases 287
Altered Ca2+ and Na+ homeostasis in human hypertrophic cardiomyopathy: Implications for arrhythmogenesis 283
Optical investigation of action potential and calcium handling maturation of hiPSC-cardiomyocytes on biomimetic substrates 283
The homozygous K280N troponin T mutation alters cross-bridge kinetics and energetics in human HCM 283
Effect of troponin Ca2+ binding properties on the kinetics of myofibril force initiation and relaxation 281
T-Tubular Electrical Defects Contribute to Blunted β-Adrenergic Response in Heart Failure. 280
A Novel Method of Isolating Myofibrils From Primary Cardiomyocyte Culture Suitable for Myofibril Mechanical Study 265
Quantitative assessment of passive electrical properties of the cardiac T-tubular system by FRAP microscopy 265
Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study 249
Design of muscle contraction assist devices by liquid crystalline elastomers 248
Liquid Crystalline Networks toward Regenerative Medicine and Tissue Repair 246
Development of Light-Responsive Liquid Crystalline Elastomers to Assist Cardiac Contraction 236
Action potential propagation in transverse-axial tubular system is impaired in heart failure 234
Real-time optical manipulation of cardiac conduction in intact hearts 231
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 230
Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human induced pluripotent stem cells 229
Arrhythmia susceptibility in a rat model of acute atrial dilation 228
Advanced Morpho-Functional Analysis on Ventricular and Atrial Tissue Reveals Cross-Bridge Kinetics Alterations and Sarcomere Energetic Impairment in Hcm Patients 228
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency 216
The Missense E258K-MyBP-C Mutation Increases the Energy Cost of Tension Generation in Both Ventricular and Atrial Tissue from HCM Patients 216
Interplay between sub-cellular alterations of calcium release and T-tubular defects in cardiac diseases 215
The relation between sarcomere energetics and the rate of isometric tension relaxation in healthy and diseased cardiac muscle 213
Beta-Blockers for Prevention of Exercise-induced Left Ventricular Outflow Obstruction in Patients with Hypertrophic Cardiomyopathy 213
The harder the climb the better the view: The impact of substrate stiffness on cardiomyocyte fate 213
The missense E258 K-MyBP-C mutation increases the energy cost of tension generation in both ventricular and atrial tissue from HCM patients 212
Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy 209
Impact of Mavacamten on Force Generation in Single Myofibrils from Rabbit Psoas and Human Cardiac Muscle 205
Myosin isoform-dependent effect of omecamtiv mecarbil on the regulation of force generation in human cardiac muscle 204
Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy 203
Impact of detubulation on force and kinetics of cardiac muscle contraction 202
Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. 200
Functional cardiac imaging by random access microscopy 196
The transverse-axial tubular system of cardiomyocytes. 196
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM 195
[Molecular targets and novel pharmacological options to prevent myocardial hypertrophic remodeling] 195
BPS2025 - Long-term effect of Mavacamten impact force and sarcomere density in a MYBPC3 iPSC-cardiomyocyte model of hypertrophic cardiomyopathy 194
Late Sodium Current Inhibition Reverses Electro-Mechanical Dysfunction in Human Hypertrophic Cardiomyopathy 193
Whole heart cytoarchitecture at micron-scale resolution 189
Optogenetic manipulation of cardiac electrical dynamics using sub-threshold illumination: dissecting the role of cardiac alternans in terminating rapid rhythms 188
Design of Biocompatible Liquid Cristal Elastomers Reproducing the Mechanical Properties of Human Cardiac Muscle 187
R4496C RyR2 mutation impairs atrial and ventricular contractility 186
Time resolved depression of isometric force by Mavacamten in single myofibrils from rabbit psoas and human cardiac muscle 181
3D imaging and morphometry of the heart capillary system in spontaneously hypertensive rats and normotensive controls 179
The HCM-associated cardiac Troponin T mutation K280N accelerates tension generation and relaxation in human cardiac myofibrils 178
Microled Illumination Towards Liquid Crystalline Elastomers Based Cardiac Contraction Assistance 176
Optogenetic confirmation of transverse‐tubular membrane excitability in intact cardiac myocytes 175
Reply to entcheva: The impact of T-tubules on action potential propagation in cardiac tissue 175
Defects in T-tubular electrical activity underlie local alterations of calcium release in heart failure 174
Mavacamten depresses human atrial contractility in the same EC50% range as human ventricle 173
Arrhythmogenic potential of myocardial disarray in hypertrophic cardiomyopathy: Genetic basis, functional consequences and relation to sudden cardiac death 170
Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function 169
Cardiomyocyte-specific Gq signalling and arrhythmias: Novel insights from DREADD technology 167
Photoresponsive Polymer-Based Biomimetic Contractile Units as Building Block for Artificial Muscles 166
Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy 166
Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations 166
Contraction and electrophysiological abnormalities in myofilament mutation-positive and mutation-negative human HCM myocardium 165
Quantification of Myocyte Disarray in Human Cardiac Tissue 165
The Role of Crosslinker Molecular Structure on Mechanical and Light-Actuation Properties in Liquid Crystalline Networks 164
EFFECTS OF CHRONIC ATRIAL FIBRILLATION ON ACTIVE AND PASSIVE FORCE GENERATION IN HUMAN ATRIAL MYOFIBRILS 163
Impact of RyR2 mutation responsible for Cathecolaminergic Polymorphic Ventricular Tachycardia (CPTV) on the short term interval-force relationship of atrial and ventricular myocardium 163
Clinical scenarios of HCM-related mortality: Relevance of age and stage of disease at presentation 160
Cellular determinants of arrhythmic rysk in hypertrophic cardiomyopathy 158
Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal 156
Response to Letter Regarding Article, "Late Sodium Current Inhibition Reverses Electromechanical Dysfunction in Human Hypertrophic Cardiomyopathy" 156
Structural Mapping of Action Potential Propagation Pathways through Healthy and Diseased Heart 156
Isolation and functional characterization of human ventricular cardiomyocytes from fresh surgical samples. 155
Age-related decline in contractile function of ventricular myofibrils from HCM patients carrying MYBPC3 mutations 155
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives 154
Impact of R4496C RyR2 mutation on myocardial contractility 153
1473Microvascular coronary disease and myocardial fibrosis within the spectrum of hypertrophic cardiomyopathy: a histopathologic study 150
Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations. 149
Mavacamten has a differential impact on force generation in myofibrils from rabbit psoas and human cardiac muscle 148
The HCM-Associated Cardiac Troponin T Mutation K273N Accelerates Tension Generation and Relaxation in Human Cardiac Myofibrils 146
Targets for therapy in sarcomeric cardiomyopathies. 146
Alpha and beta myosin isoforms and human atrial and ventricular contraction 140
Impact of E163R cTnT mutation on cardiac mechanics and energetics in a murine model 138
T-tubule remodeling in human hypertrophic cardiomyopathy 138
Letter to the Editor 133
Myocardial dysfunction in hypertrophic cardiomyopathy (HCM): primary effects of sarcomeric protein mutations versus secondary E-C coupling remodeling 130
Novel pharmacological approaches for paediatric hypertrophic cardiomyopathy 127
Myosin Binding Protein-C Mutations responsible for Hypertrophic Cardiomyophaty impair relaxation in human cardiac myofibrils 126
Optogenetics gets to the heart: A guiding light beyond defibrillation 125
Novel Optics-Based Approaches for Cardiac Electrophysiology: A Review 124
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 121
Sealing t-tubules increases the energy cost of cardiac contraction 120
Novel method of obtaining myofibrils from cardiomyocyte cultures 115
Obscurin deficiency leads to compensated dilated cardiomyopathy and increased arrhythmias 102
NaV1.8: a novel contributor to cardiac arrhythmogenesis in heart failure 99
Cap. 40: Vasi di scambio: microcircolo e sistema linfatico - In: Fisiologia Medica (Fisiologia della vita vegetativa) Vol. 2 61
Capitolo 39: Principi generali di fisiologia cardiovascolare - In: Fisiologia medica. Fisiologia della vita di relazione. Vol. 2 60
Totale 19.889
Categoria #
all - tutte 54.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.140


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022697 0 35 62 24 54 41 38 42 39 53 125 184
2022/20231.813 147 328 94 94 129 277 209 104 264 17 49 101
2023/2024814 36 80 100 39 58 107 47 192 16 39 45 55
2024/20255.065 185 551 308 729 1.321 667 105 344 220 113 211 311
2025/20266.267 597 761 458 504 799 270 727 306 468 448 203 726
2026/2027363 215 148 0 0 0 0 0 0 0 0 0 0
Totale 20.124